HOUSE DOCKET, NO. 325        FILED ON: 1/9/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1949

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

John V. Fernandes and Richard T. Moore

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to allow a sixty-day bulk purchase of prostate cancer medication.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

John V. Fernandes

10th Worcester

1/9/2013

Richard T. Moore

Worcester and Norfolk

1/23/2013

Bradley H. Jones, Jr.

20th Middlesex

1/9/2013

Cory Atkins

14th Middlesex

1/9/2013

Thomas M. Stanley

9th Middlesex

1/9/2013

Bruce E. Tarr

First Essex and Middlesex

1/9/2013

Kay Khan

11th Middlesex

1/9/2013


HOUSE DOCKET, NO. 325        FILED ON: 1/9/2013

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1949

By Representative Fernandes of Milford and Senator Richard T. Moore, a joint petition (accompanied by bill, House, No. 1949) of John V. Fernandes, Richard T. Moore and others relative to the purchase of prostate cancer medication.  Public Health.

 

[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 4534 OF 2011-2012.]

 

The Commonwealth of Massachusetts

 

_______________

In the Year Two Thousand Thirteen

_______________

 

An Act to allow a sixty-day bulk purchase of prostate cancer medication.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 23(d) of Chapter 94C of the General Laws is hereby amended by inserting after the word ,narcolepsy, the following:-provided further, that with regard to one percent testosterone, a prescription may be filled for up to a sixty-day supply of such substance upon any single filling if said substance is being used for the treatment of prostate cancer.